Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate 25 mg/1 (Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate TABLET, FILM COATED) 25 mg/1

Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate 25 mg/1 is a combination medication used in the treatment of HIV-1 infection. This oral tablet is designed to help manage the virus and support overall health.

Strength

25 mg/1

Pack Size

30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-5440-93)

Manufacturer / TM Owner

Mylan Pharmaceuticals Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate 25 mg/1 is primarily used for the treatment of HIV-1 infection. This combination medication works by targeting different stages of the HIV life cycle, helping to reduce the amount of virus in the body. It is often prescribed as part of a comprehensive treatment plan that includes other medications and lifestyle changes. People may ask, 'What is Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate used for?' primarily to manage HIV-1 infection and improve quality of life.

Side Effects

Common effects of Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate 25 mg/1 may include headaches, dizziness, nausea, and fatigue. Some individuals might experience changes in mood or sleep patterns. It's important to discuss any persistent or severe side effects with a healthcare provider.

Precautions & Warnings

Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate 25 mg/1 should be handled with care. Store the medication in a cool, dry place away from direct sunlight and out of reach of children. Always follow the prescribed dosage and administration instructions provided by your healthcare provider. Do not share this medication with others.

Avoid Interactions

Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate 25 mg/1 may interact with other medications, including certain antacids, antibiotics, and antifungal drugs. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be discussed with a healthcare provider, as it may affect the efficacy of the medication.

Frequently Asked Questions

Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate 25 mg/1 is used for the treatment of HIV-1 infection as part of a comprehensive treatment plan.

Store Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate 25 mg/1 in a cool, dry place away from direct sunlight and out of reach of children.

Common side effects may include headaches, dizziness, nausea, and fatigue. Persistent or severe side effects should be discussed with a healthcare provider.

Consult your healthcare provider about alcohol consumption while taking Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate 25 mg/1, as it may affect the medication's efficacy.

Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate 25 mg/1 may not be suitable for everyone. Always consult a healthcare provider before starting any new medication.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.